Harvard Pilgrim researchers develop model to reduce errors from sound-alike, look-alike medications

Drugs prescription pad
Researchers at the Harvard Pilgrim Health Care Institute developed and validated a data-driven prediction model to accurately predict sound-alike/look-alike medication pairs to proactively identify and prevent potential errors. (Getty/LIgorko)

A new tool could be on the horizon for identifying drugs that have similar names in order to help cut down on errors caused when prescription drugs are mixed up—or even preventing drugs from having names that are too similar to begin with.

Researchers at the Harvard Pilgrim Health Care Institute developed and validated a data-driven prediction model to accurately predict sound-alike/look-alike (SALA) medication pairs to proactively identify and prevent potential errors. Their work was presented at the American Society of Health-System Pharmacists (ASHP) summer meeting Monday.

“Even well-trained healthcare professionals can mistake one medication for another with an almost identical name," said Qoua Her, research analyst at the institute and a Harvard Medical School affiliate, in a statement. “Our new prediction model has the potential to reduce critical errors by identifying high-risk sound-alike-look-alike medication pairs.”

Free Daily Newsletter

Like this story? Subscribe to FierceHealthcare!

The healthcare sector remains in flux as policy, regulation, technology and trends shape the market. FierceHealthcare subscribers rely on our suite of newsletters as their must-read source for the latest news, analysis and data impacting their world. Sign up today to get healthcare news and updates delivered to your inbox and read on the go.

Mistakes from SALA medications contribute to as many as 250,000 hospitalizations each year from medication errors, according to the ASHP. Notably, in 2016, there were 55 reports of confusion between Brintellix, an antidepressant, and Brilinta, a blood thinner, including two serious adverse events. The U.S. Food and Drug Administration (FDA) approved a name change for Brintellix to Trintellix.   

RELATED: Pronovost's new mission: Convincing health systems to tell a different story

To conduct the study, the team from Harvard Pilgrim evaluated 82 medication name similarities and seven product attribute measures with 40,000 samples of medication pairs. They used that to create a prediction model comprised of 13 of the strongest predictors for potential medication errors, such as having the same first letter in the medication names or coming from the same manufacturer.

Suggested Articles

Memorial Sloan Kettering Cancer Center has tapped former CVS Health and Aetna executive Claus Torp Jensen, Ph.D., as its first chief digital officer.

California health officials have released their first report on the price hikes drug companies sought to shield.

Nancy Pelosi's drug prices plan would save Medicare an estimated $345 billion over seven years, according to the Congressional Budget Office.